Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
5 Stock Gainers for Friday: VBI Vaccines, Moderna, Novavax
By Rob Lenihan
Jul 17, 2020 4:23 PM EDT
PRESS RELEASES
Dynavax To Present At The H.C. Wainwright Virtual BioConnect 2021 Conference
By PR Newswire
Jan 6, 2021 4:05 PM EST
PRESS RELEASES
Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine
By PR Newswire
Dec 23, 2020 8:00 AM EST
PRESS RELEASES
European CHMP Adopts Positive Opinion For HEPLISAV-B®, Dynavax's Two Dose Adult Hepatitis B Adjuvanted Vaccine
By PR Newswire
Dec 10, 2020 4:05 PM EST
PRESS RELEASES
Clover Biopharmaceuticals Announces Positive Phase 1 Data For Its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
By Business Wire
Dec 4, 2020 3:00 AM EST
PRESS RELEASES
Dynavax To Present At The 3rd Annual Evercore Virtual ISI HealthCONx Conference
By PR Newswire
Nov 17, 2020 4:05 PM EST
PRESS RELEASES
Dynavax To Present At The Stifel 2020 Virtual Healthcare Conference
By PR Newswire
Nov 2, 2020 4:05 PM EST
PRESS RELEASES
Medigen's COVID-19 Vaccine Combined With Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy With First Participant Dosed In Early October
By PR Newswire
Oct 13, 2020 6:00 AM EDT
PRESS RELEASES
Dynavax Announces Appointment Of New Board Member And Planned Retirement Of Chief Financial Officer
By PR Newswire
Sep 24, 2020 4:05 PM EDT
PRESS RELEASES
Dynavax To Present At The H.C. Wainwright Virtual 22nd Annual Global Investment Conference
By GlobeNewswire
Aug 31, 2020 4:10 PM EDT
PRESS RELEASES
Dynavax Announces Grant To Scale Up CpG 1018 Adjuvant Capacity To Support The Global COVID-19 Response
By GlobeNewswire
Aug 13, 2020 8:00 AM EDT
PRESS RELEASES
TriSalus Life Sciences Acquires Dynavax's SD-101 Oncology Program In Purchase Agreement For Up To $250 Million In Milestone Payments Plus Royalties On Future Net Sales
By GlobeNewswire
Aug 3, 2020 8:00 AM EDT
PRESS RELEASES
Dynavax To Report Second Quarter 2020 Financial Results And Host Conference Call On August 6, 2020
By GlobeNewswire
Jul 30, 2020 4:05 PM EDT
PRESS RELEASES
Dynavax And Medigen Announce Collaboration To Develop A Novel Adjuvanted COVID-19 Vaccine Candidate
By GlobeNewswire
Jul 23, 2020 8:00 AM EDT
PRESS RELEASES
Dynavax Announces The Appointment Of Two New Board Members
By GlobeNewswire
Jul 21, 2020 4:10 PM EDT
INVESTING
5 Stock Gainers for Friday: VBI Vaccines, Moderna, Novavax
By Rob Lenihan
Jul 17, 2020 4:23 PM EDT
PRESS RELEASES
Dynavax And Mount Sinai Announce Collaboration To Develop A Universal Influenza Vaccine Candidate With CpG 1018 Adjuvant
By GlobeNewswire
Jul 16, 2020 8:40 AM EDT
PRESS RELEASES
Dynavax Announces First Participants Dosed In Phase 1 Clinical Trial Evaluating Medicago's COVID-19 Vaccine Candidate With Dynavax's CpG 1018 Adjuvant
By GlobeNewswire
Jul 14, 2020 8:00 AM EDT
PRESS RELEASES
Dynavax And Times Pharmacy Announce Partnership To Offer HEPLISAV-B® Hepatitis B Vaccine To Customers Throughout Oahu, With A Focus On People With Diabetes
By GlobeNewswire
Jul 10, 2020 4:01 PM EDT
PRESS RELEASES
Dynavax Announces First Participants Dosed In Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals' COVID-19 S-Trimer Vaccine Candidate With CpG 1018 Adjuvant
By GlobeNewswire
Jun 19, 2020 6:00 AM EDT
PRESS RELEASES
Dynavax Completes Enrollment Of Clinical Trial Evaluating HEPLISAV-B In Patients Undergoing Hemodialysis
By GlobeNewswire
Jun 9, 2020 8:00 AM EDT
PRESS RELEASES
Dynavax To Present At The William Blair 40th Annual Growth Stock Conference
By GlobeNewswire
May 28, 2020 4:05 PM EDT
PRESS RELEASES
Dynavax Technologies Announces Closing Of $80.5 Million Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
By GlobeNewswire
May 27, 2020 4:05 PM EDT
PRESS RELEASES
Dynavax Technologies Announces Pricing Of $70.0 Million Public Offering Of Common Stock
By GlobeNewswire
May 21, 2020 9:00 PM EDT
PRESS RELEASES
Dynavax Technologies Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
May 21, 2020 4:01 PM EDT
